≡ Risteys
R9

Documentation Changelog GitHub Contact & Feedback

Acrodermatitis chronica atrophicans

DOID EFO MESH SNOMED PheWeb

L12_ACRODERMATITIS

acrodermatitis chronica atrophicans: An acrodermatitis characterized by a chronically progressive course, leading to widespread atrophy of the skin. It is a clinical manifestation of Lyme borreliosis.

Endpoint definition

↥
FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 L90.4
Hospital discharge: ICD-9 7018C
Hospital discharge: ICD-8 70190
Cause of death: ICD-10 L90.4
Cause of death: ICD-9 7018C
Cause of death: ICD-8 70190

2 out of 7 registries used, show all original rules.

26

diagram downward connector

Check minimum number of events None

26

diagram downward connector

Include endpoints None

26

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

25

diagram downward connector
L12_ACRODERMATITIS

Control definitions

Control exclude L12_OTHERSKINSUBCUTIS

Extra metadata

Level in the ICD hierarchy 4
First used in FinnGen datafreeze DF2
Parent code in ICD-10 L90
Name in latin Acrodermatitis chronica atrophicans

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 25 18 7
Unadjusted prevalence (%) 0.01 0.01 0.00
Mean age at first event (years) 54.46 60.36 39.30

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: L12_ACRODERMATITIS – Acrodermatitis chronica atrophicans
GWS hits:

Survival analyses between endpoints

↥

Plot

before Acrodermatitis chronica atrophicans
after Acrodermatitis chronica atrophicans

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Acrodermatitis chronica atrophicans

↥

Endpoint not on priority list, no data to show.